Table 3. Hemorrhagic risk is evaluated by the HAS-BLED score.[48].
Letter | Clinical characteristic | Points awarded |
H | Hypertension | 1 |
A | Abnormal renal and liverfunction (1 point each) | 1 |
S | Stroke | 1 |
B | Bleeding | 1 |
L | Labile INRs | 1 |
E | Elderly (age > 65 years) | 1 |
D | Drugs or alcohol (1 point each) | 1 |
Maximum score is 9. Hypertension is defined as systolic blood pressure ≥ 160 mmHg. Abnormal kidney function is defined as the presence of chronic dialysis or renal transplantation or serum creatinine ≥ 200 mmol/L. Abnormal liver function is defined as chronic hepatic disease (e.g., cirrhosis) or biochemical evidence of significant hepatic derangement (e.g., bilirubin, 2 × upper limit of normal, in association with aspartate aminotransferase/alanine aminotransferase/alkaline phosphatase, 3 × upper limit normal, etc.). Bleeding refers to previous bleeding history and/or predisposition to bleeding, e.g., bleeding diathesis, anemia, etc. Labile INRs refers to unstable/high INRs or poor time in therapeutic range (e.g., 60%). Drugs/alcohol use refers to concomitant use of drugs, such as antiplatelet agents, non-steroidal anti- inflammatory drugs, or alcohol abuse, etc. INR: ¼ international normalized ratio.